Brickell Biotech prepares $50M at-the-market offering to fund company through Phase III trials
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) is preparing to sell up to $50 million in new stock sales to […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Brickell Biotech launches brand reset amid positioning pivot
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
Home buyers gain leverage
Realtors tend to view a housing inventory of six to seven months’ supply as a market that’s balanced between buyers…
As Ranch projects take shape, Larimer County eyes ambitious next phase
LOVELAND — Almost 5½ years after Larimer County voters approved a tax extension to fund expansion and improvements to The…